ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly 401(k) Total plan receivables ($) ($)
Form 11-K Statements of Net Assets Available for Benefits
Latest, FY2025
45,807,305
Period ended Dec 31, 2025
Change on a year earlier
+8.6%
42,190,795 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 401(k) Total plan receivables ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 45,807,305 | +8.6% | Form 11-K 2025 (filed 2026-06-23) ↗ |
| FY2024 | Dec 31, 2024 | 42,190,795 | -4.5% | Form 11-K 2024 (filed 2025-06-20) ↗ |
| FY2023 | Dec 31, 2023 | 44,187,888 | +19.6% | Form 11-K 2023 (filed 2024-06-24) ↗ |
| FY2022 | Dec 31, 2022 | 36,945,486 | +7.5% | Form 11-K 2022 (filed 2023-06-22) ↗ |
| FY2021 | Dec 31, 2021 | 34,367,763 | -2.3% | Form 11-K 2021 (filed 2022-06-27) ↗ |
| FY2020 | Dec 31, 2020 | 35,163,504 | +4.7% | Form 11-K 2020 (filed 2021-06-24) ↗ |
| FY2019 | Dec 31, 2019 | 33,573,736 | -11.2% | Form 11-K 2019 (filed 2020-06-16) ↗ |
| FY2018 | Dec 31, 2018 | 37,817,377 | -11.8% | Form 11-K 2018 (filed 2019-06-24) ↗ |
| FY2017 | Dec 31, 2017 | 42,886,854 | – | Form 11-K 2018 (filed 2019-06-24) ↗ |
Breakdown
What makes up 401(k) total plan receivables ($)
Cite this data
StockData. (2026). Eli Lilly 401(k) Total plan receivables ($) ($), annual FY2017–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/plan401k_total_rec
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.